Isotechnika Pharma Inc IPHAF

RE: $1.28 ?

[biodelatech]

let´s face it. anybody who buys isa for a 30 cent profit doesn´t get it. in the next decade this stock is 20 to 30. 1.45 or 1.76 in the near term is of no signifcance. it´s a cinch for market makers to let it drop 30 cent in a trading day for no reason. I hope I get some more below 1.30. my 20000 order is GTC. 247´s record is superb. alas it´s not cancer or aids. the average guy doesn´t get the basics of the immune system , let alone the importance of calcineurin inhibition in transplant patients. if roche takes a pass, astellas( tacrolimus maker) will be more than happy to join us.